Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 22 Aug 2006):

The changing maternal "self" hypothesis: a mechanism for maternal tolerance of the fetus.

Full Abstract

Recent advances in placental biology and immunology lead us to propose a novel hypothesis for maternal tolerance of the semi-allogeneic fetus and amelioration of rheumatoid arthritis (RA) during pregnancy. The initial event in this hypothesis is extrusion of placental apoptotic syncytiotrophoblast debris recently identified to contain intracellular fetal HLA Class II molecules, into maternal blood. The second event is uptake of apoptotic syncytiotrophoblast by immature maternal dendritic cells and presentation of fetal HLA class II peptides. In addition to presenting foreign antigens, HLA molecules also present HLA self-peptides. In the setting of the non-inflammatory environment of pregnancy, this process is expected to induce peripheral tolerance of fetal antigens through T cell death, anergy or induction of regulatory T cells in the lymph nodes. This hypothesis suggests a mechanism by which the simultaneous presentation of fetal and self (RA-associated) HLA peptides by tolerogenic dendritic cells during pregnancy may explain the observed amelioration of RA as a secondary benefit of fetal tolerance. After delivery, apoptotic syncytiotrophoblast debris disappears from maternal blood, autoimmunity returns and RA recurs. Thus, during pregnancy maternal immunologic "self" includes fetal HLA Class II as a result of apoptotic syncytiotrophoblast uptake by maternal tolerogenic dendritic cells.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Adams, K M (KM); Yan, Z (Z); Stevens, A M (AM); Nelson, J L (JL);

Affiliation: Division of Clinical Research, Fred Hutchinson Cancer Research Center, Human Immunogenetics Program, 1100 Fairview Ave. N., D2-100, P.O. Box 19024, Seattle, WA 98109-1024, USA. adamsk(-atsign-)u.washington.edu <adamsk(-atsign-)u.washington.edu>

Grants: AI41721 (Agency:NIAID NIH HHS) ; AI45659 (Agency:NIAID NIH HHS) ; AR39282 (Agency:NIAMS NIH HHS) ; AR48084 (Agency:NIAMS NIH HHS) ; HD01264 (Agency:NICHD NIH HHS)

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal: Placenta (Placenta), published in England. (Language: eng)

Reference: -2007 May-Jun; vol 28 (issue 5-6) : pp 378-82

Dates: Created 2007/04/24; Completed 2007/08/01; Revised 2007/12/03;

PMID: 16934327, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: HLA-D Antigens (0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/30/1988
5/30/2007
Higher Relevance Score (11)
Lower Relevance Score (10)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index